News | The Biomedical Scientist Magazine of the IBMS

Under the microscope: Ibuprofen

Why are we looking at ibuprofen?

Unique medical imaging framework

Researchers are developing a unique medical image processing framework aimed at helping oncologists treat lung cancer tumours more effectively.

COVID-19 not characterised by a cytokine storm

Inflammatory proteins known as cytokines play a crucial role in the immune response. If this response is too strong – a phenomenon known as “cytokine storm” – it can cause harm to the patient.

Immunology

"Genome sequencing accelerates cancer detection"

Researchers at the University of Cambridge, EMBL’s European Bioinformatics Institute (EMBL-EBI), and collaborators sequenced genomes from biopsies routinely collected from patients with B

Molecular Pathology & Genomics

Uncovering order in cancer's chromosomal chaos

Their findings could bring us a step closer to an “evolutionary rule book” to help predict and block cancer’s next move.

Molecular Pathology & Genomics

Patient zero discovered?

The new research probes the threat of airborne infection by taking a close look at passengers who made a 50-minute trip to a Buddhist event in the eastern Chinese city of Ningbo aboard tw

Microbiology & Virology

HSST programme: enhanced flexibility

The move means a broadening of the eligibility criteria for the Higher Specialist Scientific Training (HSST) Programme.

IBMS comment of replacing PHE

It says: “The IBMS recognises that the current lack of clarity on how the new institute will be structured is causing a great deal of anxiety amongst many of our members who are employed

The Biomedical Scientist Live

The CPD event is called The Biomedical Scientist Live and is set to take place from 16 to 19 November.

COVID 19: "More T cell data needed"

This claim comes from Daniel Altmann and Rosemary Boyton from Imperial College London in a new paper.

Microbiology & Virology

"Three times risk for frontline healthcare workers"

Those with inadequate PPE had a further increase in risk, while healthcare workers from Black, Asian and minority ethnic (BAME) backgrounds are more likely to test positive.

Immunology